Andrew R. Haas

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer”.

Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102301

N/A

0.429DataRank · unranked

14 citations

Charly R. Good, Julie S. Barber-Rotenberg, Sangya Agarwal, Wesley V. Wilson, Alex Watts +27 more

Recanalization of Complete Airway Stenosis After Blunt Force Chest Trauma

The American Journal of Medicine(2020)10.1016/j.amjmed.2020.06.035

N/A

0DataRank · unranked

0 citations

C. Kevin, Andrew R. Haas, Roger Y. Kim

Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial

Lung Cancer(2021)10.1016/j.lungcan.2021.01.011

N/A

0DataRank · unranked

19 citations

Leonid Roshkovan, Ian Berger, Joseph S. Friedberg, Evan Alley, Charles B. Simone +5 more

Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100188

N/A

0DataRank · unranked

4 citations

Nandita Mitra, Stephen Bagley, Melina E. Marmarelis, Andrew R. Haas, Katharine A. Rendle +2 more

Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity

Molecular Therapy(2020)10.1016/j.ymthe.2020.11.001

N/A

0DataRank · unranked

35 citations

Andrew R. Haas, Marina C. Martinez, Shaun O’Brien, Edmund K. Moon, Patrick Woodruff +14 more

Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100301

N/A

0DataRank · unranked

34 citations

Charu Aggarwal, Janeline Wong, Vivek Nimgaonkar, Wei‐Ting Hwang, Michelle Andronov +17 more

Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.2526

N/A

0DataRank · unranked

14 citations

Xiao Wang, Leonid Roshkovan, Connor B. Grady, John T. Miura, Michelle S. Ginsberg +15 more

Microbiome Profiling Demonstrates Concordance of Endotracheal Tube Aspirates With Direct Lower Airway Sampling in Intubated Patients

CHEST Journal(2024)10.1016/j.chest.2024.01.007

N/A

0DataRank · unranked

3 citations

Jevon Graham-Wooten, Samantha A. Whiteside, Ayannah S. Fitzgerald, Layla A. Khatib, C. Kevin +6 more

Histologic Subtype Informs Real-World Immune Checkpoint Inhibitor Uptake in Patients with Malignant Pleural Mesothelioma

(2021)10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4760

N/A

0DataRank · unranked

0 citations

N. K. Mitra, Stephen Bagley, Melina E. Marmarelis, Andrew R. Haas, Katharine A. Rendle +2 more